Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Champions Oncolog (CSBR)

Champions Oncolog (CSBR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Champions Oncolog One University Plaza Suite 307 Hackensack NJ 07601 USA

www.championsoncology.com Employees: 213 P: 201-808-8400

Sector:

Medical

Description:

Champions Oncology, Inc., formerly known as Champions Biotechnology, Inc., engages in the development of advanced technology solutions to personalize the development and use of oncology drugs. The Company's Tumorgraft Technology Platform is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune deficient mice followed by propagation of the resulting engraftments. This technology can evaluate tumor sensitivity/resistance to various single, combination standard and novel chemotherapy agents. Champions Oncology, Inc. is based in Baltimore, Maryland.

Key Statistics

Overview:

Market Capitalization, $K 98,452
Enterprise Value, $K 88,662
Shares Outstanding, K 13,886
Float, K 7,362
% Float 53.02%
Short Interest, K 77
Short Float 0.56%
Days to Cover 3.65
Short Volume Ratio 0.23
% of Insider Shareholders 46.98%
% of Institutional Shareholders 41.30%

Financials:

Annual Sales, $ 56,940 K
Annual Net Income, $ 4,700 K
Last Quarter Sales, $ 15,040 K
Last Quarter Net Income, $ 270 K
EBIT, $ 2,440 K
EBITDA, $ 4,080 K

Growth:

1-Year Return -35.35%
3-Year Return 72.51%
5-Year Return -35.43%
5-Year Revenue Growth 77.27%
5-Year Earnings Growth 294.12%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.02 on 12/15/25
Next Earnings Date 03/10/26
Earnings Per Share ttm 0.17
EPS Growth vs. Prev Qtr 166.67%
EPS Growth vs. Prev Year -60.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-12 on 08/12/15

CSBR Ratios

Ratio
Price/Earnings ttm 41.18
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 58.62%
Return-on-Assets % 8.06%
Profit Margin % 8.25%
Debt/Equity 0.00
Price/Sales 1.71
Price/Cash Flow 15.26
Price/Book 22.79
Book Value/Share 0.31
Interest Coverage -1.27
60-Month Beta 0.35
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar